Obsessive-Compulsive Disorder — Symptoms, Causes & Treatment | MyMedicPlus

Obsessive-compulsive disorder (OCD) is a chronic, debilitating neuropsychiatric condition characterised by the presence of obsessions (recurrent, intrusive, unwanted thoughts, images, or urges that provoke marked anxiety or distress) and compulsions (repetitive mental acts or physical behaviours performed in response to obsessions, according to rigid rules, or aimed at preventing a feared event — providing only temporary anxiety relief). OCD is formally classified as an obsessive-compulsive and related disorder in the DSM-5 and ICD-11, distinct from anxiety disorders, personality disorders, and psychotic spectrum illness. It has a lifetime prevalence of 2-3% globally — affecting over 70 million people — with no significant sex difference in adults, though boys are more commonly affected in childhood. OCD is ranked by the WHO as one of the ten most disabling medical conditions worldwide, due to its severely impairing impact on occupational, social, and interpersonal functioning. The defining feature distinguishing OCD from normal intrusive thoughts (which virtually all humans experience) is the ego-dystonic quality of obsessions — the thoughts are experienced as repugnant, deeply unwanted, and contrary to the person's values and sense of self — combined with the time-consuming (often 3-8 hours daily), distress-causing nature of the compulsive response. The average diagnostic delay is 7-10 years, primarily because of shame, misdiagnosis, and delayed help-seeking — despite highly effective treatments being available.

The aetiology of OCD is multifactorial, involving neurobiological, genetic, and environmental contributions. Neurobiological basis: functional neuroimaging consistently demonstrates hyperactivation of the cortico-striato-thalamo-cortical (CSTC) circuit in OCD — particularly the orbitofrontal cortex (OFC), which drives cognitive appraisal of threat and harm, and the caudate nucleus, which normally gates the habitual behavioural output. In OCD, this circuit generates excessive 'danger signals' (obsessions) and compulsive motor programmes (compulsions) that fail to be inhibited normally. Serotonin neurotransmission plays a central modulatory role in CSTC function — evidenced by the specific efficacy of serotonin reuptake inhibitors (SSRIs and clomipramine) in OCD at doses higher than needed for depression; dopamine neurotransmission in the striatum also contributes (explaining why antipsychotic augmentation is beneficial in partial SSRI responders). Glutamate system dysregulation is an emerging therapeutic target. Genetic factors: heritability estimates of 40-65% from twin studies; OCD is 4x more common in first-degree relatives of affected individuals; childhood-onset OCD has higher heritability. No single gene has been identified; polygenic risk includes variants in SLC1A1 (glutamate transporter), HTR2A (serotonin receptor), and SAPAP3 (synapse-associated protein). Environmental and precipitating factors: childhood trauma and emotional abuse; psychosocial stressors (bereavement, significant life events); pregnancy and the peripartum period (postpartum OCD is an underrecognised but common onset point); and PANDAS (Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections — abrupt childhood OCD onset following group A streptococcal infection, mediated by anti-neuronal antibodies). OCD symptom dimensions: contamination and washing; symmetry, exactness and ordering; harm obsessions with checking compulsions; taboo/forbidden thoughts (sexual, religious, aggressive — intrusive thoughts about self or others, deeply egodystonic); and hoarding (now a separate diagnosis in DSM-5).

OCD manifests through a cyclical pattern of obsessions triggering anxiety, compulsive responses providing temporary relief, and reinforcement of the cycle through negative reinforcement. Obsessions are unwanted, intrusive, recurrent thoughts, images, or urges experienced as ego-dystonic — i.e., the person knows they are a product of their own mind yet finds them deeply repugnant and contrary to their values. Common obsession themes: contamination fears (germs, illness, chemical contamination); harm obsessions (fear of accidentally or intentionally harming oneself or loved ones — causing intense guilt and shame despite no wish to cause harm); symmetry and exactness obsessions (sense that things must be 'just right,' intense discomfort when asymmetric or incomplete); taboo intrusive thoughts (sexual thoughts involving children, blasphemous religious thoughts, violent thoughts — all ego-dystonic and deeply unwanted); and health obsessions ('pure O' health anxiety in OCD). Compulsions are repetitive behaviours (handwashing, checking locks, touching rituals, counting, repeating words silently, seeking reassurance, ordering objects) performed to reduce obsessional anxiety or prevent feared outcomes — though they provide only temporary relief and inevitably escalate. Common compulsive patterns: excessive handwashing or showering (often causing dermatitis from repeated washing); repeatedly checking gas taps, locks, or electrical appliances; counting or repeating phrases a specified number of times; seeking repeated reassurance from family members. Avoidance behaviour — avoiding situations that trigger obsessions — compounds functional disability. Insight varies: most OCD patients recognise the irrationality of obsessions at least intermittently, but in severe states 'poor insight' OCD resembles psychosis. Shame and concealment cause an average 7-10 year diagnostic delay — the average GP consultation reveals OCD only after 5-7 appointments for related anxiety or depression.

OCD is diagnosed clinically through structured psychiatric assessment based on DSM-5 and ICD-11 criteria. DSM-5 diagnostic criteria require: the presence of obsessions and/or compulsions; that obsessions or compulsions are time-consuming (consuming more than 1 hour per day) OR cause clinically significant distress or functional impairment in social, occupational, or other domains; and that the symptoms are not attributable to the direct physiological effects of a substance or another medical condition. Crucially, OCD has poor introspective recognition — patients rarely volunteer their OCD symptoms at initial appointments due to shame, and brief direct questioning is needed: 'Do you have recurring thoughts you find distressing and can't control?' and 'Do you feel compelled to perform repetitive rituals?' The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) — a clinician-administered semi-structured interview rating obsession severity (0-20), compulsion severity (0-20), and total severity (0-40) — is the gold standard for measuring severity and monitoring treatment response; scores above 16 indicate moderate-severe OCD requiring active treatment. Key differential diagnoses requiring careful exclusion: OCD personality disorder (OCPD — ego-syntonic perfectionism, orderliness, and rigidity without true ego-dystonic obsessions); generalised anxiety disorder (obsession-like worry is goal-directed and reactive, not ego-dystonic); body dysmorphic disorder (BDD — preoccupation with perceived appearance defect — treated similarly to OCD with ERP and SSRIs); tic disorders and Tourette syndrome (comorbid with OCD in 20-30%); and schizophrenia or psychosis (poor insight OCD may resemble delusions but lacks the first-rank Schneiderian features of psychosis).

OCD treatment is highly effective, with 70-80% of patients achieving significant improvement with appropriate intervention. NICE CG31 recommends a stepped care model. Step 1-3 (mild to moderate OCD): low-intensity CBT with ERP via guided self-help or computerised programmes; Step 4 (moderate to severe): 10 hours of CBT/ERP with a trained therapist plus SSRI if psychological treatment is ineffective or declined; Step 5 (severe/treatment-resistant): specialist multidisciplinary team including intensive/daily ERP, SSRI optimisation, and augmentation. Exposure and Response Prevention (ERP): the gold-standard psychological treatment — the patient is systematically exposed to feared stimuli or situations triggering obsessional anxiety (in person, through imaginal exercises, or via in vivo exposure in everyday situations) while deliberately refraining from performing the compulsive response. This allows anxiety to peak and then decline naturally through habituation — weakening the learned fear association and demonstrating that feared catastrophes do not occur. ERP achieves 60-70% response rates when delivered adequately (at least 10 sessions). SSRI pharmacotherapy: all licensed SSRIs are effective for OCD — fluvoxamine (100-300mg/day), sertraline (50-200mg/day), fluoxetine (20-60mg/day), paroxetine (20-60mg/day), and escitalopram (10-20mg/day). SSRIs must be prescribed at higher doses than used for depression and response typically takes 8-12 weeks; 12-week adequate SSRI trial before considering an alternative. Clomipramine (a TCA with potent serotonin reuptake inhibition) is as effective as SSRIs but with a worse side-effect profile (anticholinergic, cardiac QTc prolongation) — used second-line. Combined ERP plus SSRI is superior to either alone. Augmentation for partial SSRI responders: low-dose risperidone (0.5-2mg) or haloperidol (for tic-related OCD). Ketamine infusions show short-term benefit in refractory OCD. Deep brain stimulation (DBS) and anterior capsulotomy are last-resort interventions for severely treatment-resistant OCD.

Severe OCD causes profound functional disability — in the most severe cases, patients are unable to work, maintain relationships, leave their home, or perform basic self-care activities due to the time consumed by rituals. OCD is associated with high rates of psychiatric comorbidity: major depressive disorder occurs in 40-50% of OCD patients (often secondary to the demoralisation and functional impairment caused by OCD), with worsening prognosis when comorbid; anxiety disorders (generalised anxiety disorder, panic disorder, social anxiety disorder) are present in over 75% of patients. Tic disorders and Tourette syndrome co-occur in 20-30% of OCD patients, particularly in male and childhood-onset cases — tic-related OCD responds better to antipsychotic augmentation than tic-absent OCD. Eating disorders and body dysmorphic disorder are related conditions with overlapping features and shared pathophysiology. Suicidality is a critical complication: suicidal ideation is present in approximately 50% of OCD patients over their lifetime, and suicide attempt rates are approximately 15% — substantially higher than population norms; suicidal risk is often concealed due to shame about intrusive thoughts (particularly harm obsessions), leading to underestimation of risk. Family member 'accommodation' of OCD — participating in rituals or avoiding triggers to reduce the patient's distress — inadvertently maintains and worsens OCD, causing significant family dysfunction and caregiver burnout.

While OCD cannot be prevented in individuals with biological predisposition, early identification and treatment substantially reduce the duration of suffering, severity of impairment, and chronicity. Achieving a diagnosis within 1-2 years of symptom onset (rather than the current average of 7-10 years) is the single most impactful preventive goal — requiring improved public and clinical awareness, school-based mental health literacy, and reduction of stigma. Long-term maintenance therapy reduces relapse: SSRI maintenance for at least 1-2 years after achieving remission significantly reduces the 40-80% relapse risk seen after acute discontinuation. Maintenance ERP booster sessions (monthly or 3-monthly) sustain response after completing an acute ERP programme and should be built into all OCD management plans. Reducing family accommodation: psychoeducation for family members explaining that participating in rituals or avoiding triggers inadvertently maintains and worsens OCD — graduated reduction of family accommodation, ideally with therapist guidance, is essential. Peer support groups (OCD Action, OCD-UK) reduce isolation, provide practical coping strategies, and normalise help-seeking. Mindfulness-Based Cognitive Therapy (MBCT) and acceptance and commitment therapy (ACT) complement ERP by helping patients observe intrusive thoughts without engaging with them. Addressing PANDAS: prompt antibiotic treatment of confirmed group A streptococcal infections in children with OCD may limit symptom exacerbations in PANDAS cases.

Seek mental health support as soon as possible if: unwanted repetitive thoughts or rituals are consuming more than 1 hour per day; OCD symptoms are significantly interfering with work, relationships, social life, or daily functioning; the distress caused by obsessions is severe, causing significant anxiety, depression, or isolation; you are feeling suicidal or engaging in self-harm — OCD patients have a 50% lifetime rate of suicidal ideation and 15% rate of suicide attempts, often without disclosing to others due to shame about intrusive thoughts. Go to A&E or call a crisis line immediately if you are experiencing thoughts of suicide or self-harm. See your GP to begin the referral pathway for CBT-ERP and SSRI treatment — average diagnostic delay for OCD is 7-10 years due to shame and concealment, but effective treatments are available. You do not need to be ashamed of OCD symptoms — intrusive thoughts that are ego-dystonic (deeply unwanted and contrary to your values) are a key feature of OCD and not a reflection of your character or desires. Early referral to a specialist OCD clinic or clinical psychologist trained in ERP achieves the best outcomes.